Design, synthesis of 4-aminoquinoline-derived thiazolidines and their antimalarial activity and heme polymerization inhibition studies

References

• Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S. Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov 2004;3:509–520.
   PubMed Web of Science ®Google Scholar
• Wiesner J, Ortmann R, Jomaa H, Schlitzer M. New antimalarial drugs. Angew Chem Int Ed Engl 2003;42:5274–5293.
   PubMed Web of Science ®Google Scholar
• Ridley RG. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 2002;415:686–693.
   PubMed Web of Science ®Google Scholar
• Kaur K, Jain M, Reddy RP, Jain R. Quinolines and structurally related heterocycles as antimalarials. Eur J Med Chem 2010;45:3245–3264.
   PubMed Web of Science ®Google Scholar
• Ridley RG, Hofheinz W, Matile H, Jaquet C, Dorn A, Masciadri R et al. 4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum. Antimicrob Agents Chemother 1996;40:1846–1854.
   PubMed Web of Science ®Google Scholar
• De D, Krogstad FM, Byers LD, Krogstad DJ. Structure-activity relationships for antiplasmodial activity among 7-substituted 4-aminoquinolines. J Med Chem 1998;41:4918–4926.
   PubMed Web of Science ®Google Scholar
• Stocks PA, Raynes KJ, Bray PG, Park BK, O’Neill PM, Ward SA. Novel short chain chloroquine analogues retain activity against chloroquine resistant K1 Plasmodium falciparum. J Med Chem 2002;45:4975–4983.
   PubMed Web of Science ®Google Scholar
• Pandey AV, Bisht H, Babbarwal VK, Srivastava J, Pandey KC, Chauhan VS. Mechanism of malarial haem detoxification inhibition by chloroquine. Biochem J 2001;355:333–338.
   PubMedGoogle Scholar
• Dorn A, Stoffel R, Matile H, Bubendorf A, Ridley RG. Malarial haemozoin/beta-haematin supports haem polymerization in the absence of protein. Nature 1995;374:269–271.
   PubMed Web of Science ®Google Scholar
• Egan TJ, Marques HM. The role of haem in the activity of chloroquine and related antimalarial drugs. Coord Chem Rev 1999;190–192:493–517.
   Web of Science ®Google Scholar
• Sullivan DJ Jr, Matile H, Ridley RG, Goldberg DE. A common mechanism for blockade of heme polymerization by antimalarial quinolines. J Biol Chem 1998;273:31103–31107.
   PubMed Web of Science ®Google Scholar
• Ziegler J, Linck R, Wright DW. Heme Aggregation inhibitors: antimalarial drugs targeting an essential biomineralization process. Curr Med Chem 2001;8:171–189.
   PubMed Web of Science ®Google Scholar
• Solomon VR, Puri SK, Srivastava K, Katti SB. Design and synthesis of new antimalarial agents from 4-aminoquinoline. Bioorg Med Chem 2005;13:2157–2165.
   PubMed Web of Science ®Google Scholar
• Solomon VR, Haq W, Srivastava K, Puri SK, Katti SB. Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives. J Med Chem 2007;50:394–398.
   PubMed Web of Science ®Google Scholar
• Solomon VR, Haq W, Smilkstein M, Srivastava K, Rajakumar S, Puri SK et al. Synthesis and antimalarial activity of novel side chain modified antimalarial agents derived from 4-aminoquinoline. Med Chem 2008;4:446–456.
   PubMedGoogle Scholar
• Solomon VR, Haq W, Smilkstein M, Srivastava K, Puri SK, Katti SB. 4-Aminoquinoline derived antimalarials: synthesis, antiplasmodial activity and heme polymerization inhibition studies. Eur J Med Chem 2010;45:4990–4996.
   PubMed Web of Science ®Google Scholar
• Deshpande S, Solomon VR, Katti SB, Prabhakar YS. Topological descriptors in modelling antimalarial activity: N(1)-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine as prototype. J Enzyme Inhib Med Chem 2009;24:94–104.
   PubMed Web of Science ®Google Scholar
• Prabhakar YS, Solomon VR, Gupta MK, Katti SB. QSAR studies on thiazolidines: A biologically privileged scaffold. In: Gupta SP ed Topics in Heterocyclic Chemistry. Berlin, Heidelberg, Germany: Springer, 2006, Vol. 4, pp. 161–249.
   Google Scholar
• Lesyk RB, Zimenkovsky BS. 4-Thiazolidones: Centenarian history, current status and perspectives for modern organic and medicinal chemistry. Curr Org Chem 2004;8:1547–1577.
   Web of Science ®Google Scholar
• Prabhakar YS, Jain P, Khan ZK, Haq W, Katti SB. Synthesis and QSAR studies on the antifungal activity of 2,3,4-substituted thiazolidines. QSAR Comb Sci 2003;22:456–465.
   Google Scholar
• Rawal RK, Solomon VR, Prabhakar YS, Katti SB, De Clercq E. Synthesis and QSAR studies on thiazolidinones as anti-HIV agents. Comb Chem High Throughput Screen 2005;8:439–443.
   PubMedGoogle Scholar
• Srivastava T, Gaikwad AK, Haq W, Sinha S, Katti SB. Synthesis and biological evaluation of 4-thiazolidinone derivatives as potential antimycobacterial agents. ARKIVOC 2005; ii:120–130.
   Google Scholar
• Srivastava K, Puri SK. Plasmodium falciparum: modified medium composition supports continuous cultivation with foetal bovine serum. Exp Parasitol 2004;108:74–75.
   PubMedGoogle Scholar
• Puri SK, Singh N. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys. Exp Parasitol 2000;94:8–14.
   PubMedGoogle Scholar
• Egan TJ, Mavuso WW, Ross DC, Marques HM. Thermodynamic factors controlling the interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX. J Inorg Biochem 1997;68:137–145.
   PubMed Web of Science ®Google Scholar
• Tripathi AK, Khan SI, Walker LA, Tekwani BL. Spectrophotometric determination of de novo hemozoin/beta-hematin formation in an in vitro assay. Anal Biochem 2004;325:85–91.
   PubMed Web of Science ®Google Scholar
• GraphPad Prism, version 4.03. GraphPad Software Inc., 10855 Sorrento Valley Rd. #203, San Diego, CA 92121, 2005.
   Google Scholar
• Pallas 2.0. Compu-Drug Chemistry Ltd., San Francisco, CA, 1995.
   Google Scholar